These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4032351)

  • 1. The spread of type A influenza.
    Hope-Simpson RE
    J R Coll Gen Pract; 1985 Jun; 35(275):267-9. PubMed ID: 4032351
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community.
    McMinn P; Carrello A; Cole C; Baker D; Hampson A
    Clin Infect Dis; 1999 Aug; 29(2):456-8. PubMed ID: 10476769
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of the host on the phase transformations of an influenza virus population].
    Skripchenko GS; Vlasova AG; Rybakova TM
    Vestn Akad Med Nauk SSSR; 1983; (5):28-34. PubMed ID: 6868801
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antigen load and storability of sensitized microtiter plates for influenza virus ELISA].
    Rosmus K; Griessmann K; Borkhardt HL
    Z Gesamte Hyg; 1985 Nov; 31(11):649-50. PubMed ID: 4090550
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological and epidemiological aspects of the persistence of the influenza virus].
    Golubev DB; Medvedeva MN
    Vestn Akad Med Nauk SSSR; 1983; (5):34-9. PubMed ID: 6868803
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamics of annual influenza A epidemics with immuno-selection.
    Andreasen V
    J Math Biol; 2003 Jun; 46(6):504-36. PubMed ID: 12783180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Universal influenza vaccine still far in the future].
    Rimmelzwaan GF; Osterhaus AD
    Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2305-7. PubMed ID: 10589217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiology of influenza in Leningrad in 1979-1981].
    Briantsev EA; Kaplun IIa; Efimenko IB
    Tr Inst Im Pastera; 1982; 59():15-20. PubMed ID: 6228041
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antigenic heterogeneity of human influenza virus type A populations and its role in the epidemic process].
    Beliakov VD; Golubev DB; Zuev VA; Karpukhin GI; Medvedeva MN
    Vestn Akad Med Nauk SSSR; 1983; (5):23-8. PubMed ID: 6191450
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic analysis of influenza A viruses.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Mar; 30(9):110-1. PubMed ID: 6789137
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of the influenza A virus antigen in pharyngeal swabs using an enzyme immunoassay].
    Helbig JH; Muschner K; Füssel E; Witzleb W
    Z Gesamte Hyg; 1986 Oct; 32(10):615-7. PubMed ID: 3544534
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription.
    Mukhtar MM; Li S; Li W; Wan T; Mu Y; Wei W; Kang L; Rasool ST; Xiao Y; Zhu Y; Wu J
    Int J Biochem Cell Biol; 2009 Mar; 41(3):554-60. PubMed ID: 18687409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antigenic variability of Hong Kong influenza viruses circulating in Poland in 1969-1980].
    Zgorzelska K
    Med Dosw Mikrobiol; 1982; 34(3-4):159-66. PubMed ID: 6188933
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influenza surveillance in Belgium, 1979-1980. Performance of serological studies in military recruits].
    Mombaerts-Servais M; van Vliet-Husson J
    Arch Belg Med Soc; 1980; 38(5-6):313-22. PubMed ID: 7212708
    [No Abstract]   [Full Text] [Related]  

  • 16. [The antigenic-immunogenic activity of the trivalent polymer-subunit influenza vaccine Grippol in a controlled epidemiological trial (2)].
    El'shina GA; Masalin IuM; Shervarli VI; Gorbunov MA; Lonskaia NI; Agafonova LV; Khaitov RM; Nekrasov AV; Ivanova AS
    Voen Med Zh; 1996 Nov; 317(11):53-5. PubMed ID: 9036633
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preparation and characteristics of the antigenic properties of tissue influenza diagnostic agents].
    Sominina AA; Korchanova NL; Lisok TP; Rumel' NB; Sverdlov AB
    Tr Inst Im Pastera; 1982; 59():67-70. PubMed ID: 7187571
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccines and veterinarians to tackle the spread of avian influenza.
    J Am Vet Med Assoc; 2006 Apr; 228(7):999-1000. PubMed ID: 16596749
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence vaccination: comparison of the effectiveness of two different vaccines].
    Kuwert E; Thraenhart O; Werner J; Höher PG
    Med Klin; 1980 Oct; 75(21):755-8. PubMed ID: 7453623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.